Ping Xi
Xinyu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The deubiquitinase YOD1 suppresses tumor progression by stabilizing ZNF24 in clear cell renal carcinoma.
Journal: Cell death & disease
Published: October 31, 2024
Astaxanthin Alleviates Chronic Prostatitis via the ERK1/2 Signaling Pathway: Evidence from Network Pharmacology and Experimental Validation.
Journal: Combinatorial chemistry & high throughput screening
Published: May 17, 2024
A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma.
Journal: Aging
Published: September 13, 2023
Astaxanthin alleviates chronic prostatitis/chronic pelvic pain syndrome by increasing colonization of Akkermansia muciniphila in the intestine.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 12, 2023
Multidimensional comprehensive and integrated analysis of the potential function of TMEM25 in renal clear cell carcinoma with low expression status.
Journal: Aging
Published: September 04, 2023
A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma.
Journal: Frontiers in pharmacology
Published: July 25, 2022
Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
Journal: Hereditas
Published: July 17, 2022
A novel prognostic model based on cellular senescence-related gene signature for bladder cancer.
Journal: Frontiers in oncology
Published: May 06, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026